Introduction and Objective: Twenty-five parents of pediatric patients (age 8-17) diagnosed with type 1 diabetes (T1D) within one year participated in The T1D Parent Check-in telehealth intervention. To build rapport and set context, parents were asked to tell their “diagnosis story” - sharing their family’s experience of new diagnosis. Qualitative thematic analysis reveals insight into what caregivers and families need from healthcare professionals and the diabetes community at diagnosis. Methods: Parents participated in a semi-structured interview about their experience of diagnosis in session one. Interviews were conducted by licensed psychologists, recorded, and transcribed. Team-based reflexive thematic analysis was used to develop a codebook. Data were coded and analyzed with NVivo 11 software to group statements by themes. Parents self-reported diabetes related distress at baseline. Results: Consistent with Bronfenbrenner’s theory, adjustment to diagnosis occurs across system levels including individual (child / parent), family (immediate / extended), healthcare, schools/ other societal contexts and is influenced by culture and sociodemographics. Themes reflected in parent distress included guilt, present and future worry, and overwhelm of information. Experiences varied depending on timing and severity of symptoms at diagnosis (e.g. DKA). Parent distress was high at baseline (PAID M = 47.84, SD = 17.13, clinical cutoff = 40). Conclusion: The first year of a child’s diagnosis of T1D is a time of heightened stress for primary caregivers. Healthcare professionals and the diabetes community should address parental guilt and worry and overwhelm of information. Parent / caregiver perspectives can inform interventions and provide insight for supporting families. We will share strategies addressed in The T1D Parent Check-in and discuss potential implications for diagnosis in early (e.g. via screening) versus late-stage T1D. Disclosure E. O'Donnell: Consultant; Current; Eddii Inc. W. Grolnick: None. K. Garvey: Speaker's Bureau; Ended; Tandem Diabetes Care, Inc. G. Ding: None. A.J. Wheelock: None. D. Mitra: None. N. Doble: None. A.J. Caruso: None. Funding Breakthrough T1D
O'Donnell et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: